Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > SNDL is going to push all POT stocks higher today
View:
Post by Conister011 on Jan 28, 2021 8:48am

SNDL is going to push all POT stocks higher today

Pulled my short yesterday and went long.  Glad I did as SNDL will move POT market today.  Glta
Comment by KTMFan387 on Jan 28, 2021 9:03am
Good to see the Reddit army starting to turn their attention to this heavily shorted segment.  Let's point them at LABS and see how many shorts lose their shirts. https://investorplace.com/2021/01/sndl-stock-cannabis-play-sundial-growers-flies-high-on-reddit-stocks-rally/
Comment by alleyesonme on Jan 28, 2021 12:03pm
1.5 billion volume on sundial. Reddit army is powerful no doubt! 5.95 % shares shorted on sundial. 3.67 on labs. Maybee when there done bankrupting sndl shorters they'll turn their attention over here.
Comment by Conister011 on Jan 28, 2021 3:13pm
Regardless, I am all in now, bought in at .64 and .63.  Glta
Comment by alleyesonme on Jan 28, 2021 3:55pm
All in here to! Been building a position for a while now. Was thinking int update would of come already, maybee next week. 1st quarter earnings EST should be easy to surpass. Valuation very low compared to its peers. Tolling contracts orders may be a big surprise boost based on them being so low in the 3rd quarter and a mention on "timing". short squeeze on the horizon. Glta.
Comment by lscfa on Jan 28, 2021 3:58pm
Medipharm was probably ready to report some intl. news but Valens writedowns tanked the extractors again so now waiting for market to calm down.    
Comment by flad101 on Jan 28, 2021 4:32pm
She will drop a bit more. Just just a few more cents and I'll cover my short.  Imagine that iscfa I made the right call Again. Lol. Keep pumping my friend you create the believers that I make money on. Thanks. 
Comment by Conister011 on Jan 29, 2021 12:02am
I am leaving all my shorts this week including this one.  The market is now hyper focused on any co that has a lot of short interest regardless of fundamentals.   Could turn even a sound short trade very bad very quickly.  Good luck
Comment by Lemoyne on Jan 28, 2021 4:41pm
I thought intl news would porbably come out when stada shipments were done and be news that would group multiple aspects rear (Q4) and forward looking (Stada/Q1 2021). Stada shipments should happen in february so news could come out in second half of Q1. Maybe CFO announcement coming soon as we are 2.5 months since search began. You can google CannabiStada Extrakt (probable brand under which ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities